These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 33611340)

  • 1. Identification of biomarkers and pathways for the SARS-CoV-2 infections that make complexities in pulmonary arterial hypertension patients.
    Taz TA; Ahmed K; Paul BK; Al-Zahrani FA; Mahmud SMH; Moni MA
    Brief Bioinform; 2021 Mar; 22(2):1451-1465. PubMed ID: 33611340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of Biochemical Processes between Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension (PAH), and Coronavirus Disease 2019 (COVID-19).
    Tian Z; Cen L
    Pol J Microbiol; 2023 Jun; 72(2):143-154. PubMed ID: 37216361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network-based identification genetic effect of SARS-CoV-2 infections to Idiopathic pulmonary fibrosis (IPF) patients.
    Taz TA; Ahmed K; Paul BK; Kawsar M; Aktar N; Mahmud SMH; Moni MA
    Brief Bioinform; 2021 Mar; 22(2):1254-1266. PubMed ID: 33024988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unravels the Influences of SARS-CoV-2 Infections to Cancer Patients.
    Chen Y; Qin Y; Fu Y; Gao Z; Deng Y
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics and system biology approach to identify the influences of COVID-19 on cardiovascular and hypertensive comorbidities.
    Nashiry A; Sarmin Sumi S; Islam S; Quinn JMW; Moni MA
    Brief Bioinform; 2021 Mar; 22(2):1387-1401. PubMed ID: 33458761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovering Common Pathophysiological Processes between COVID-19 and Cystic Fibrosis by Differential Gene Expression Pattern Analysis.
    Hasan MT; Abdulrazak LF; Alam MK; Islam MR; Sathi YH; Al-Zahrani FA; Ahmed K; Bui FM; Moni MA
    Biomed Res Int; 2022; 2022():8078259. PubMed ID: 35528173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patients.
    Mahmud SMH; Al-Mustanjid M; Akter F; Rahman MS; Ahmed K; Rahman MH; Chen W; Moni MA
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33847347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenetic profiling of COVID-19 and SARS-like viruses.
    Nain Z; Rana HK; Liò P; Islam SMS; Summers MA; Moni MA
    Brief Bioinform; 2021 Mar; 22(2):1175-1196. PubMed ID: 32778874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transcriptomic profiling of SARS-CoV-2 compared to SARS, MERS, EBOV, and H1N1.
    Alsamman AM; Zayed H
    PLoS One; 2020; 15(12):e0243270. PubMed ID: 33301474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFI44 is an immune evasion biomarker for SARS-CoV-2 and
    Zheng Q; Wang D; Lin R; Lv Q; Wang W
    Front Immunol; 2022; 13():1013322. PubMed ID: 36189314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
    Ahmed FF; Reza MS; Sarker MS; Islam MS; Mosharaf MP; Hasan S; Mollah MNH
    PLoS One; 2022; 17(4):e0266124. PubMed ID: 35390032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diseasome and comorbidities complexities of SARS-CoV-2 infection with common malignant diseases.
    Satu MS; Khan MI; Rahman MR; Howlader KC; Roy S; Roy SS; Quinn JMW; Moni MA
    Brief Bioinform; 2021 Mar; 22(2):1415-1429. PubMed ID: 33539530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: Insights from machine learning and bioinformatics approaches.
    Hoque MN; Sarkar MMH; Khan MA; Hossain MA; Hasan MI; Rahman MH; Habib MA; Akter S; Banu TA; Goswami B; Jahan I; Nafisa T; Molla MMA; Soliman ME; Araf Y; Khan MS; Zheng C; Islam T
    Front Immunol; 2022; 13():918692. PubMed ID: 36059456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncovering common pathobiological processes between COVID-19 and pulmonary arterial hypertension by integrating Omics data.
    Wang RS; Loscalzo J
    Pulm Circ; 2023 Jan; 13(1):e12191. PubMed ID: 36721384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling of SARS-CoV-2 infections reveal distinct primary lung cell and systemic immune infection responses that identify pathways relevant in COVID-19 disease.
    Moni MA; Quinn JMW; Sinmaz N; Summers MA
    Brief Bioinform; 2021 Mar; 22(2):1324-1337. PubMed ID: 33333559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of pancreatic adenocarcinoma following SARS-CoV family infection.
    Ebrahimi Sadrabadi A; Bereimipour A; Jalili A; Gholipurmalekabadi M; Farhadihosseinabadi B; Seifalian AM
    Sci Rep; 2021 Jun; 11(1):12948. PubMed ID: 34155232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Target and drug predictions for SARS-CoV-2 infection in hepatocellular carcinoma patients.
    Wang L; Ding Y; Zhang C; Chen R
    PLoS One; 2022; 17(5):e0269249. PubMed ID: 35639708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of common molecular signatures of SARS-CoV-2 infection and its influence on acute kidney injury and chronic kidney disease.
    Zhang W; Liu L; Xiao X; Zhou H; Peng Z; Wang W; Huang L; Xie Y; Xu H; Tao L; Nie W; Yuan X; Liu F; Yuan Q
    Front Immunol; 2023; 14():961642. PubMed ID: 37026010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of potential therapeutic drugs against SARS-CoV-2 by using Connectivity Map based on transcriptome data.
    Chen WY; Fang ZX; Lv XD; Zhou QH; Yao M; Deng M
    Eur Rev Med Pharmacol Sci; 2021 Apr; 25(7):3122-3131. PubMed ID: 33877681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 patients may become predisposed to pulmonary arterial hypertension.
    Suzuki YJ; Nikolaienko SI; Shults NV; Gychka SG
    Med Hypotheses; 2021 Feb; 147():110483. PubMed ID: 33444904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.